- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 12.8M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.36M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.07M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $677.06K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $745.6K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $12.56M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $12.34M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $12.66M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $12.43M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.82M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $3.75K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $290.95K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $11M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $10.8M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.02 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.02 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $145.3K |
| Net Income | Q1 2025 · Mar 31, 2024 | $197.4K |
| Operating Income | Q1 2025 · Mar 31, 2024 | $175.19K |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.4M |